Literature DB >> 35861948

The Role of Blood-Brain Barrier Dysfunction in Mild Cognitive Impairment: a Scientometric and Visualization Analysis from 2000 to 2021.

Ming Cai1,2, Si Chen3, Yihong Du4, Siqi Li3, Peihai Dong3, Liyan Wang5, Ruoyu Yang5, Jingyun Hu6, Lei Zhu7.   

Abstract

Mild cognitive impairment (MCI) is a pathological stage between normal cognitive aging and dementia. The blood-brain barrier (BBB) breakdown is emerging as an early biomarker of MCI. This study aimed to visually analyze the literatures related to MCI caused by BBB dysfunction in recent 20 years, systematically identify collaboration networks, track research trends, highlight current hot spots, and predict future frontiers in this field. The related literatures published from 2000 to 2021 were obtained from the Web of Science with the search term "mild cognitive impairment and (blood-brain barrier or neurovascular unit or neurovascular coupling)". VOSviewer software was used to present knowledge map, CiteSpace software was used to extract literature information and make tables, including the top most influential countries, authors, institutions, periodicals, keywords, and references. A total of 333 literatures were used for visual analysis. After 2013, the literatures in the field of BBB dysfunction-induced MCI showed an increased trend in terms of year of publication and quantity of material, with more than 40 publications published each year. USA, England, China, and Sweden cooperated closely. In terms of institutions, Harvard Med Sch ranked first in the number of papers published, followed by Mstricht Univ and Univ Washington. In terms of journals, three of the top five co-cited journals belonged to USA, the other two journals were Neurobiol Aging and J Alzheimers DIS, which were from England and Netherlands respectively. A total of 1752 authors were identified, with Abhay P Sagare the most published and Zlokovic BV the most cited. Keyword emergence detection analysis showed that inflammation, oxidative stress, and memory were new research hot spot in this field. Overall, the research on BBB dysfunction-induced MCI is booming. In the future, cooperation and communication between different countries and institutions should be strengthened.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bibliometric analysis; Blood–brain barrier; CiteSpace; Mild cognitive impairment; VOSviewer; Web of Science

Mesh:

Year:  2022        PMID: 35861948     DOI: 10.1007/s12031-022-02052-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   2.866


  41 in total

1.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 2.  Structure and function of the blood-brain barrier.

Authors:  N Joan Abbott; Adjanie A K Patabendige; Diana E M Dolman; Siti R Yusof; David J Begley
Journal:  Neurobiol Dis       Date:  2009-08-05       Impact factor: 5.996

Review 3.  The effects of aging in the hippocampus and cognitive decline.

Authors:  Luis E B Bettio; Luckshi Rajendran; Joana Gil-Mohapel
Journal:  Neurosci Biobehav Rev       Date:  2017-05-02       Impact factor: 8.989

Review 4.  Diagnosis and Management of Dementia: Review.

Authors:  Zoe Arvanitakis; Raj C Shah; David A Bennett
Journal:  JAMA       Date:  2019-10-22       Impact factor: 56.272

Review 5.  State of the science on mild cognitive impairment (MCI).

Authors:  Nicole D Anderson
Journal:  CNS Spectr       Date:  2019-01-17       Impact factor: 3.790

Review 6.  Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer's disease.

Authors:  Ansab Akhtar; Sangeeta Pilkhwal Sah
Journal:  Neurochem Int       Date:  2020-02-21       Impact factor: 3.921

Review 7.  Blood-Brain Barrier Overview: Structural and Functional Correlation.

Authors:  Abeer Alahmari
Journal:  Neural Plast       Date:  2021-12-06       Impact factor: 3.599

8.  Hippocampus in health and disease: An overview.

Authors:  Kuljeet Singh Anand; Vikas Dhikav
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

9.  Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease.

Authors:  Marije R Benedictus; Annebet E Leeuwis; Maja A A Binnewijzend; Joost P A Kuijer; Philip Scheltens; Frederik Barkhof; Wiesje M van der Flier; Niels D Prins
Journal:  Eur Radiol       Date:  2016-06-22       Impact factor: 5.315

Review 10.  Functional cognitive disorder: dementia's blind spot.

Authors:  Harriet A Ball; Laura McWhirter; Clive Ballard; Rohan Bhome; Daniel J Blackburn; Mark J Edwards; Stephen M Fleming; Nick C Fox; Robert Howard; Jonathan Huntley; Jeremy D Isaacs; Andrew J Larner; Timothy R Nicholson; Catherine M Pennington; Norman Poole; Gary Price; Jason P Price; Markus Reuber; Craig Ritchie; Martin N Rossor; Jonathan M Schott; Tiago Teodoro; Annalena Venneri; Jon Stone; Alan J Carson
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.